Maintain vigilance
over patient safety by ensuring the call light is in reach, the bed is in the lowest position, upper side rails up, and bed alarm on when appropriate
Unfortunately, sometimes profits take priority
over patient safety.
The negligence often stems from the hospital or HMO's preference for profits
over patient safety.
Not exact matches
Product
safety is unusually sensitive in China following scandals
over the past decade in which infants, hospital
patients and others have been killed or sickened by phoney or adulterated milk powder, drugs and other goods.
Although the FDA can't dictate prices or reject therapies
over pricing concerns (they can only focus on
safety and efficacy), the agency can encourage more competition through moves like this (as well as speedier approval pathways) which could spur drug makers to produce products that ultimately lower costs for
patients — a goal cited by FDA Commissioner Scott Gottlieb in announcing the list.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror
patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured
patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and
patients may not see advantages of these products
over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs;
safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Analyzing medical death rate data
over an eight - year period, John Hopkins
patient safety experts have calculated that more than 250,000 deaths per year are due to medical error in the United States.
Additionally, the proportion of
patients in the United States who are prescribed opioids for non-cancer pain has almost doubled
over the past decade, indicating the need to do a more focused examination on the
safety and efficacy of these and other treatment options.
«By considering that stethoscopes are used repeatedly
over the course of a day, come directly into contact with
patients» skin, and may harbor several thousands of bacteria (including MRSA) collected during a previous physical examination, we consider them as potentially significant vectors of transmission,» commented lead investigator Didier Pittet, MD, MS, Director of the Infection Control Program and WHO Collaborating Centre on
Patient Safety, University of Geneva Hospitals.
As for the
safety of medical marijuana as an opioid alternative, one of the most extensive reports to date was published late last year in the Journal of Pain and followed about 200
patients using cannabis for chronic pain
over 12 months.
«Study allays concerns
over aspirin's
safety for heart failure
patients.»
Have a strong reputation in our region for utilizing the most effective care practices, as well as maintaining the highest levels of
patient safety and satisfaction, leading
patients to consistently choose UConn Health medical and dental clinical services
over other providers.
We have faced previous periods when intrinsic value investing was out of favor, and we know that the key to delivering outsized long - term returns is owning good businesses at large margins of
safety of value
over price and remaining
patient.
Physical Requirements: • Able to lift
patients and carry equipment up to 50 pounds; ability to lift
patients or carry equipment
over 50 pounds with assistance • Endure sitting, standing and walking on hard floor surfaces for extended periods • Type information for
patient records and prescription labels into the computer • Able to work in noisy work conditions with sounds from animals and equipment • Take
safety precautions for exposure to toxins, drugs, anesthesia and radiation • Must be able to travel to other clinics as well.
Also a top concern is anesthesia
safety; many ADCNW
patients are
over eight years old.
I have enjoyed using Zoetis products
over the decades for their efficacy and
safety in the dermatologic
patients I have treated.
With the use of better drugs and
safety protocols anesthesia in dogs is relatively safe, as
over 99 % of
patients survive.
Referring veterinarians are welcome to consult with the cardiology department regarding follow - up care; however, concerns regarding prompt care and
patient safety dictate that we can not provide owners or referring veterinarians with treatment recommendations for
patients that are not directly under our care or
patients that have not been seen in
over 6 months.
Over the past few decades, Oklahoma has passed a number of specific nursing home abuse laws, most recently in 2013; the laws were amended to allow for video surveillance in private rooms to help improve the
safety of
patients further.
We think it is essential that
patient safety is prioritised
over profit, regardless of whether people are treated through the NHS or privately - and currently, the laws in force do not mean this is the case.
Although Actos has been available to diabetes users in the US for a number of years, it was just last year that the Food and Drug Administration put out a Drug
Safety Communication giving notification that the medication's label had been revised to include a warning that use of the drug for
over a year dramatically increases the chances that the
patient might develop bladder cancer.
This requirement gives victims control
over decision making about their health information where their
safety could be at issue, helps promote trust between
patients and providers, and is consistent with health care providers» ethical obligation to seek
patient authorization whenever possible before disclosing protected health information.
In his Friday letter, Principal Thompson asked families «to be
patient with these new procedures, and hopefully
over time, we will be able to fine tune the process, while maintaining the
safety / security.»
• Effectively able to maintain constant vigilance
over patients by taking necessary
safety precautions.